Explore FHI 360

Practice Area

Health

For FHI 360, improving the health of the world's women, men and children is core to our mission.

Published research

Women’s experience receiving drug feedback and adherence counseling in MTN-025/HOPE-an HIV prevention open-label trial of the dapivirine vaginal ring

Event

FHI 360 at the International Conference on Family Planning 2022

FHI 360 is pleased to join the global community of family planning and sexual and reproductive health experts at the International Conference on Family Planning (ICFP) 2022. For over 50 years, FHI 360 has been providing cutting-edge leadership in...

Feature

Meet the women researching the future of contraception

To build future contraceptive researchers, FHI 360 partnered with the Bill & Melinda Gates Foundation in 2022 to create the Emerging Leaders in Contraceptive Technology Innovation mentorship program.

Project

Research on Scale-up of the Hormonal IUD in New and Emerging Markets (SHINE)

SHINE will generate evidence to inform the introduction and scale-up of the hormonal IUD and support future introduction of similar family planning methods.

Tools

Envision FP: Seven Years of Success

This flipbook describes Envision FP’s achievements in pharmaceutical development, clinical research and product introduction from 2015 to 2022.

Published research

Does the ring work? Perceptions and understanding of the efficacy of a dapivirine vaginal ring for HIV prevention amongst women in a placebo-controlled trial

Published research

Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: A multicenter phase 3 trial

Published research

Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa

Tools

Updated Couple Years of Protection: Literature Review, Guidance for Updating Existing Methods, and Adding New Methods

This couple years of protection (CYP) brief synthesizes findings relevant to CYP for USAID and includes background information about the CYP development and revision process for the family planning field.

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Health

Women’s experience receiving drug feedback and adherence counseling in MTN-025/HOPE-an HIV prevention open-label trial of the dapivirine vaginal ring

FHI 360 at the International Conference on Family Planning 2022

Meet the women researching the future of contraception

Research on Scale-up of the Hormonal IUD in New and Emerging Markets (SHINE)

Envision FP: Seven Years of Success

Does the ring work? Perceptions and understanding of the efficacy of a dapivirine vaginal ring for HIV prevention amongst women in a placebo-controlled trial

Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: A multicenter phase 3 trial

Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa

Updated Couple Years of Protection: Literature Review, Guidance for Updating Existing Methods, and Adding New Methods

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

68 Results Found